Your search matched 55 results
Approved: First CBD-based Prescription Drug, for Treatment of Epilepsy | Blog
A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.
F.D.A. | Blog
An expert panel that advises U.S. federal regulatory authorities has recommended approval of Esketamine, Johnson & Johnson’s brand-new treatment for depression.
Where will digital therapeutics or DTx be in five years?
Johnson & Johnson, Alongside Uber and McDonald’s, Eliminates CMO Role | Blog
The elimination of CMOs at Johnson & Johnson, Uber and McDonalds highlights how marketing technologies are changing marketing at its core.
Zipline Drones Achieve Universal Health Care Delivery in Rwanda. | Blog
With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.
Alexa, Upend My Fixed Conceptions of Healthcare in America | Blog
Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.
AI Predicts Drug Interactions Like We Never Could | Blog
Complications from drug interactions can present patients with whole new afflictions.
Scientists to Monitor Diabetes Through Color-Changing Tattoos | Blog
Though pioneering a brand-new health-monitoring technology, scientists at the Technical University of Munich are doing it through an ancient art: tattoos.
Why Pharma’s a Friend of the Pod | Blog
Pharmaceutical leaders are meeting customers in their AirPods, according to iHeartMedia President Conal Byrne, because audio is a newly critical space for American content consumption.
If You’ve Been the Victim of Medical Malpractice, Don’t Yelp About It | Blog
The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.
In Return for Your Foodstagrams, Your Blood, and Your DNA, Nestlé Offering Smoothies | Blog
Nestlé, the brand you might associate first with such decadent confections as Crunch bars, Laffy Taffy, and Toll House cookies, has made a decided turn toward the healthful.
Big Healthcare Brands Warming to Blockchain | Blog
A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.
Lyft Offering (Some) Free Rides to the Hospital | Blog
Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.
Psychiatric Trials Supercharged by Otsuka’s Science 37 Collab | Blog
Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.
Roche’s “Floodlight” a Multiple Sclerosis Game Changer | Blog
Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.
WalMart May Enlist Doctors to Help Beat Amazon in Tug-of-War | Blog
To retail behemoths, the health care realm is growing irresistible.
Required List Price Disclosures on TV Pushes Pharma Further Into Digital | Blog
A recent proposal by the U.S.
Orphan Drugs More Promising than Ever | Blog
The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.
More Clinical Trials for More Women Thanks to Advantia, Elligo | Blog
Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.
Pharmacists Reduce Opioid Use by 50% in Kaiser Permanente Study | Blog
In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.
Geisinger CEO Poached by Google to Drive Healthcare Strategy | Blog
After taking some major leaps into healthcare, Google has begun solidifying its foothold in the space by appointing Dr.
Pfizer, Novartis Align Against Liver Disease | Blog
Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.
Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.
Medical Data Processing Disrupted by Amazon | Blog
Amazon Web Services (AWS) has unveiled new machine-learning tools reflecting—and beginning to tackle—some of the greatest challenges facing modern medicine.
GSK Gains Targeted Therapy, Footing in Boston with $5.1-billion Tesaro Buy | Blog
GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.
Amazon Deploys Legion of Micro-influencers, Accepting Applications for More | Blog
While the term “micro-influencer” may still sound to you like some flippant, gen-Z farce, the side hustle cum way of life just scored serious validation.
Digital Medicine and MedTech Showcase: What’s Blocking the Adoption of Digital Therapeutics? | Blog
With there being so many different stakeholders, including patients, providers and payers, panelists at the 2019 Digital Medicine & MedTech Showcase pointed to a number of different adoption roadblocks—and successes.
Cannabis Firm Tilray Scores Partnership with Novartis | Blog
Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.
Apps to Push Prescription Drugs Over the Counter | Blog
In the first half of this new year, the United States FDA will incentivize many pharmaceutical brands to make their biggest prescription drugs available over the counter.
Already have a RSS feed reader?
